Our Hoofing IT Champions:
HOOFING IT! 2026 Total Raised $31,515
2026 Campaign: Hoofing IT 2026 raised $31,515 for NET cancer research!
Thank you to all our donors!
Final Results
HOOFING IT! 2026:
Raised $31,515!
Thank you to all our donors!

Public Listings for Caprelsa

Caprelsa (vandetanib) is indicated for the treatment of symptomatic or progressive Medullary thyroid cancer in adult patients with unresectable locally advanced or metastatic disease. Alberta Health Services has put the [...]

By |2018-09-18T23:32:14-04:00September 18th, 2018|Treatment News|Comments Off on Public Listings for Caprelsa

Patient Input – Treatment with Telotristat

TELOTRISTAT is an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in adult patients with metastatic neuroendocrine tumours.The company who makes telotristat [...]

By |2018-09-03T18:47:17-04:00September 3rd, 2018|Survey, Treatment News|Comments Off on Patient Input – Treatment with Telotristat
Go to Top